Pfizer and BioNTech received first authorization in European Union for COVID-19 vaccine in adolescents
On May 28, 2021, Pfizer and BioNTech announced that the Conditional Marketing Authorization for COMIRNATY in the European…
-
-
Patient enrollment reached 90 percent in Innovation Pharma’s phase 2 clinical trial of brilacidin for COVID-19
On May 27, 2021, Innovation Pharma announced that patient enrollment in the Company’s 120-patient, Phase 2 clinical trial…
-
Seattle Children’s researchers discovered that functional COVID-19 antibodies are lost quickly after mild cases
On May 27, 2021, Seattle Children’s researchers published a study that uncovered a deeper understanding of why people…
-
Biotechnology | Diagnostics | FDA | Infectious Disease | NIH | Therapeutics
NIAID scientists found that Salmonella use intestinal epithelial cells to colonize the gut
On May 26, 2021, National Institutes of Health (NIH) scientists reported that the immune system’s attempt to eliminate…
-
Henry Schein awarded Strategic National Stockpile contract for PPE storage and distribution
On May 26, 2021, Henry Schein announced the Company was awarded a $53.4 million contract from the U.S….
-
Biotechnology | Cartoons - Original | CDC | COVID-19 | FDA | Infectious Disease | Therapeutics | Vaccine
The Wave
The Wave Cartoon Illustrates how unprepared the U.S. was when the COVID-19 wave hit our shores despite the…
-
Health Canada approved Quidel’s Sofia’ SARS antigen FIA test for screening asymptomatic populations
On May 24, 2021, Quidel announced that its Sofia® SARS Antigen FIA is the first rapid antigen test…
-
Moderna and Aldevron announced expanded partnership for mRNA vaccine and therapeutic pipeline
On May 24, 2021, Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Aldevron, the…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics
FDA approved first targeted therapy for subset of non-small cell lung cancer
On May 21, 2021, The Janssen Pharmaceutical Companies of Johnson & Johnson announced the U.S. Food and Drug…
-
G20 leaders boosted support of the Access to COVID-19 Tools Accelerator
On May 21, 2021, world leaders the Global Health Summit adopted an agenda to overcome the COVID-19 pandemic,…
-
EMA issued positive scientific opinion on GSK and Vir Biotechnology’s sotrovimab for the early treatment of COVID-19
On May 21, 2021, GlaxoSmithKline and Vir Biotechnology announced that the European Medicines Agency’s (EMA) Committee for Human Medicinal…
-
APEIRON Biologics’ APN01 selected for large-scale U.S. trial in COVID-19
On May 19, 2021, APEIRON Biologics announced the next development steps for APN01 (alunacedase alfa) for the treatment…
-
Thermo Fisher and University of California, San Francisco announced cell therapy cGMP manufacturing and collaboration center
On May 19, 2021, Thermo Fisher Scientific and the University of California, San Francisco (UCSF) announced they have…
-
Scientists discovered rare genetic condition that attacks kids’ immune systems
On May 19, 2021, Megan A. Cooper, MD, PhD, an associate professor of pediatrics at Washington University School…
-
Sanofi and GSK COVID-19 vaccine candidate demonstrated strong immune responses across all adult age groups in Phase 2 trial
On May 17, 2021, Sanofi and GSK reported that their adjuvanted recombinant COVID-19 vaccine candidate achieved strong rates…
-
Oxford University and Oracle Partner to speed identification of COVID-19 variants
On May 17, 2021, Oxford University and Oracle have created a Global Pathogen Analysis System (GPAS) combining Oxford’s…
-
Preliminary data suggested mixing Covid-19 vaccine increases reactogenicity
On May 13, 2021, University of Oxford researchers reported that Com-COV study data comparing mixed dosing schedules of…
-
The ALS Society of BC awarded $2 million for PROJECT HOPE to establish ALS research professorship at UBC
On May 12, 2021, the province of British Columbia provided the ALS Society of BC with $2 million…
-
Gene therapy restored immune function in children with rare immunodeficiency
On May 10, 2021, the National Institutes of Health (NIH) reported that an investigational gene therapy can safely…
-
GSK and Vir Biotechnology announced start of the EMA rolling review of VIR-7831 (sotrovimab) for early treatment of COVID-19
On May 7, 2021, GlaxoSmithKline and Vir Biotechnology announced that the European Medicines Agency (EMA) has started a…
-
Hoth Therapeutics and Virginia Commonwealth University expanded research agreement for COVID-19 therapeutic
On May 5, 2021, Hoth Therapeutics announced it has expanded its sponsored research agreement with Virginia Commonwealth University…
-
CytoDyn reaches agreement with Albert Einstein Israelite Hospital in Brazil to conduct two COVID-19 trials
On May 5, 2021, CytoDyn announced an agreement to partner with the Albert Einstein Israelite Hospital (AEIH) in…
-
Pfizer and BioNTech submitted request to expand conditional marketing authorization of COMIRNATY in EU to adolescents
On Apr. 29, 2021, Pfizer and BioNTech announced they had submitted a variation to the Conditional Marketing Authorization…
-
Biotechnology | Cartoons - Original | CDC | COVID-19 | Diagnostics | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | USDA | Vaccine | WHO
COVID-19 science and reason
COVID-19 and it’s naysayers are attacking Science and Reason. The defenders must suffer the slings and arrows from…
-
Biotechnology | COVID-19 | Disease | Infectious Disease | Oncology | Rare Disease | Therapeutics | Vaccine
Moderna announced agreement with Sanofi for manufacturing of Moderna COVID-19 Vaccine in the U.S.
On Apr. 26, 2021, Sanofi has entered into an agreement with Moderna, under which Sanofi will help manufacture Moderna´s…
-
NIH established new childhood asthma clinical research network
On Apr. 23, 2021, the National Institute of Allergy and Infectious Diseases (NIAID) announced that it had awarded…
-
Biotechnology | Disease | Genomics | Oncology | Therapeutics
Mayo Clinic study found colon cancer driven by hereditary gene mutations in 1 in 6 patients
On Apr. 19, 2021, the Mayo Clinic announced a study that bolstered evidence that colorectal cancer is often…
-
Tonix Pharma entered worldwide licensing agreement to develop antiviral SARS-CoV-2 inhibitor for treatment of COVID-19
On Apr. 19, 2021, Tonix Pharmaceuticals and OyaGen announced an exclusive worldwide licensing agreement for an antiviral inhibitor…
-
Biotechnology | COVID-19 | Diagnostics | Genomics | Infectious Disease | Non-Profit Research | Therapeutics
Texas A&M lab identified new COVID-19 variant; genome suggested potential resistance to antibodies
On Apr. 19, 2021, scientists at the Texas A&M University Global Health Research Complex (GHRC) announced they had…
-
CytoDyn submitted Most Crucial Section of interim order to Health Canada for COVID-19 under rolling review
On Apr. 19, 2021, CytoDyn announced it had submitted the manufacturing section (CMC) of the application for an…
